Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus

NCT00035984 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

734

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Non-Insulin-Dependent

Interventions

DRUG: AC2993
DRUG: AC2993
DRUG: Placebo
DRUG: Placebo

Sponsor

AstraZeneca